Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79.6M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
8.92M
-
Shares change
-
-123K
-
Total reported value, excl. options
-
$12.2M
-
Value change
-
-$169K
-
Number of buys
-
11
-
Number of sells
-
-15
-
Price
-
$1.37
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q3 2023
35 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.92M shares
of 79.6M outstanding shares and own 11.2% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.33M shares), ARMISTICE CAPITAL, LLC (1.82M shares), VANGUARD GROUP INC (675K shares), Woodline Partners LP (604K shares), Ensign Peak Advisors, Inc (443K shares), CM Management, LLC (235K shares), GEODE CAPITAL MANAGEMENT, LLC (176K shares), Royal Bank of Canada (158K shares), RENAISSANCE TECHNOLOGIES LLC (62K shares), and JMAC ENTERPRISES LLC (58K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.